Wedbush Securities Inc Astrazeneca PLC Transaction History
Wedbush Securities Inc
- $2.7 Billion
- Q3 2024
A detailed history of Wedbush Securities Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Wedbush Securities Inc holds 7,496 shares of AZN stock, worth $503,581. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,496
Previous 23,062
67.5%
Holding current value
$503,581
Previous $1.8 Million
67.54%
% of portfolio
0.02%
Previous 0.06%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...